Effectiveness of Seasonal Malaria Chemoprevention in Children under Ten Years of Age in Senegal: A Stepped-Wedge Cluster-Randomised Trial

1. World Health Organization (2012) WHO Policy Recommendation: Seasonal Malaria Chemoprevention (SMC) for Plasmodium falciparum malaria control in highly seasonal transmission areas of the Sahel sub-region in Africa. March 2012. (In English and French). http://www.who.int/malaria/publications/atoz/who_smc_policy_recommendation/en/index.html

2. World Health Organization (2011) Report of the Technical consultation on Seasonal Malaria Chemoprevention (SMC) Geneva 4–6 May 2011. http://www.who.int/malaria/publications/atoz/smc_report_teg_meetingmay2011/en/index.html

3. Cairns M, Roca-Feltrer A, Garske T, Wilson AL, Diallo D, Milligan PJM et al. (2012) Estimating the potential public health impact of seasonal malaria chemoprevention in African children. Nat Commun, 3, 881. doi: 10.1038/ncomms1879 22673908

4. WHO (2012) Seasonal Malaria Chemoprevention with sulfadoxine-pyrimethamine plus amodiaquine in children. A Field Guide. November 2012. WHO:Geneva.

5. http://impact.ref.ac.uk/CaseStudies/CaseStudy.aspx?Id=41452

6. http://www.malariaconsortium.org/what-we-do/projects/41/access-smc

7. Okiro EA, Al-Taiar A, Reyburn H, Idro R, Berkley JA, Snow RW (2009) Age patterns of severe paediatric malaria and their relationship to Plasmodium falciparum transmission intensity. Malaria Journal 8:4 doi: 10.1186/1475-2875-8-4 19128453

8. Noor AM, Kibuchi E, Mitto B, Coulibaly D, Doumbo OK, Snow RW (2015) Sub-National Targeting of Seasonal Malaria Chemoprevention in the Sahelian Countries of the Nouakchott Initiative. PLoS ONE 10(8): e0136919. doi: 10.1371/journal.pone.0136919 26322634

9. NDiaye JL, Cissé B, Ba EH, Gomis JF, Ndour CT, Molez JFet al. (2016) Safety of Seasonal Malaria Chemoprevention (SMC) with sulfadoxine-pyrimethamine plus amodiaquine when delivered to children under 10 years of age by district health services in Senegal. PLoS ONE 11(10): e0162563. doi: 10.1371/journal.pone.0162563 27764102

10. Cisse B, Sokhna C, Boulanger D, Milet J, Ba EH, Richardson K et al. (2006) Seasonal intermittent preventive treatment with artesunate and sulfadoxine-pyrimethamine for prevention of malaria in Senegalese children: a randomised, placebo-controlled, double-blind trial. The Lancet, 367, 659–667.

11. Sokhna C, Cisse B, Ba EH, Milligan P, Hallett R, Sutherland C et al. (2008) A trial of the efficacy, safety and impact on drug resistance of four drug regimens for seasonal intermittent preventive treatment in Senegalese children. PLoS ONE 3: e1471. doi: 10.1371/journal.pone.0001471 18213379

12. Brown CA and Lilford RJ (2006) The stepped wedge trial design: a systematic review. BMC Medical Research Methodology 6:54 doi: 10.1186/1471-2288-6-54 17092344

13. Heming K and Girling A (2014) A menu-driven facility for power and detectable-difference calculations in stepped-wedge cluster-randomized trials. Stata Journal 14(2):363–380.

14. Lo AC, Faye B, Ba EH, Cisse B, Tine R, Abiola A et al. (2013) Prevalence of molecular markers of drug resistance in an area of seasonal malaria chemoprevention in children in Senegal. Malaria Journal 12:137 doi: 10.1186/1475-2875-12-137 23617576

15. David Sinclair, Martin M Meremikwu, and Paul Garner (2012) Seasonal Malaria Chemoprevention for preventing malaria morbidity in children aged less than 5 years living in areas of marked seasonal transmission: GRADE tables to assist guideline development and recommendations—background document for inaugural MPAC meeting 2012. [http://www.who.int/malaria/mpac/feb2012/smc_grade_tables.pdf].

16. Trape J-F, Sauvage C, Ndiaye O, Douillot L, Marra A, Diallo A et al. (2012) New Malaria-Control Policies and Child Mortality in Senegal: Reaching Millennium Development Goal 4. Journal of Infectious Diseases 205:672–679 doi: 10.1093/infdis/jir805 22238469